LFMD LifeMD, Inc.

LifeMD (formerly Conversion Labs) is a rapidly growing direct to consumer telemedicine and wellness company. In addition to our proven online marketing expertise, we have built a technology platform, online pharmacy infrastructure and nationwide physician network to treat patients, prescribe prescription medications, and ship prescription and over the counter medications directly to patients in all 50 states. We believe telemedicine will transform the American healthcare system by increasing access to care and improving outcomes. We’re proud to be a leader in this rapidly evolving space.

$7.52
As of 09/16/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Staples
Industry:  Pharmaceutical Retailers
Index country:  USA
Country of incorporation:  USA
IPO date:  07/11/2001
Outstanding shares:  26,562,800
Average volume:  369,480
Market cap:   $199,752,256
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    53216B104
ISIN:        US53216B1044
Sedol:      BMXDBQ2
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy